Sort
48,018 grants matching “immunotherapy”
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$796,412Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA
Post-exposure immunotherapy for ricin exposure
$796,370Miles Burke Brennan · Zabbio, Inc. · R44 · FY2020 · AI
Fibroblast Heterogeneity in Pancreatic Cancer
$796,363David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$796,220Jeffrey S Miller · University Of Minnesota · R35 · FY2018 · CA
Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina
$796,050Maya Koronyo-Hamaoui · Cedars-Sinai Medical Center · R01 · FY2025 · AG
Induction of autophagy to enhance CAR-T cells in HIV cure approaches
$795,998Anjie Zhen · University Of California Los Angeles · R01 · FY2022 · AI
PHILADELPHIA PEDIATRIC AIDS CLINICAL TRIALS UNIT
$795,976Children'S Hospital Of Philadelphia · U01 · FY2000 · AI
Exploring Siglec-glycan ligand interactions using chemoenzymatic approaches
$795,942Peng Wu · Scripps Research Institute, The · R01 · FY2022 · AI
Dramatic CD4+ T cell depletion without simian AIDS in SIV+ mangabeys
$795,770Donald L Sodora · Seattle Biomedical Research Institute · R56 · FY2010 · AI
Adoptive Cellular Therapies to Enhance Tolerance and Protective Immunity
$795,622Leslie S Kean · Emory University · U19 · FY2008 · AI
Single-cell DNA methylation analysis of human cancer
$795,613Kenneth Aldape · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Monoclonal Antibodies for Alzheimer's Immunotherapy
$795,545Andrew C Hiatt · Mapp Biopharmaceutical, Inc. · R44 · FY2008 · AG
Clinical Trials Engine to Develop an HIV Cure study to test engineered T cells
$795,497Christina M Coughlin · University Of Pennsylvania · U19 · FY2024 · AI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$795,459Rafick-Pierre Sekaly · Emory University · U54 · FY2020 · CA
Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication
$795,229Binhua Ling · Texas Biomedical Research Institute · R01 · FY2023 · MH
Comprehensive antigenic mapping of the human anti-peanut IgE antibody response
$795,181Scott Alan Smith · Vanderbilt University Medical Center · R01 · FY2024 · AI
Immunotherapeutic targeting of gangliosides in Ewing Sarcoma
$795,150Robbie G. Majzner · Dana-Farber Cancer Inst · U01 · FY2023 · CA
Lymphoma Studies
$795,122Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Mechanisms of immunopathology of COVID-19/ARDS, and strategies to mitigate detrimental inflammatory responses
$795,038Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Immune Control and Evasion during Acute HCV Infection
$795,032Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2012 · AI
Immune Control and Evasion during Acute HCV Infection
$795,032Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2014 · AI
Blood-brain barrier and microstructural brain biomarkers of ARIA and treatment outcomes with anti-amyloid immunotherapy for Alzheimer's disease
$794,981Emilie T. Reas · University Of California, San Diego · R01 · FY2025 · AG
Clinical and Translational Investigations of Immune Suppression and Immune Modulation in Glioblastoma
$794,779Edjah Nduom · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Developing preclinical xenograft models in zebrafish.
$794,628David Michael Langenau · Massachusetts General Hospital · R24 · FY2022 · OD
Developing preclinical xenograft models in zebrafish.
$794,628David Michael Langenau · Massachusetts General Hospital · R24 · FY2024 · OD